Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Disease

This Stock Is Tripling on a Key Gene Therapy Win. Should You Buy the 200%-Plus Surge Now?

Uniqure shares skyrocket as the biotech firm announces a major breakthrough in Huntington’s disease. Here’s why investors should wait before initiating a new position in QURE stock.

Barchart

What's Going On With UniQure Stock Wednesday?

UniQure N.V. (NASDAQ:QURE) shares are trading higher Wednesday after the company announced positive topline results from Phase I/II study of AMT-130 in patients with Huntington’s Disease.

Benzinga

'Groundbreaking' gene therapy is first treatment for Huntington's disease to slow the condition

Results from a three-year trial suggest an experimental gene therapy for Huntington's disease can slow the progression of the deadly condition by 75%.

LiveScience

From analysis to the latest developments in health,
read the most diverse news in one place.

‘This new treatment brings hope’ – families on Huntington’s treatment

Huntington’s disease is a fatal neurological condition.

Evening Standard

First Successful Gene Therapy for Huntington's Disease Slows Disease Progression by 75%

In a landmark clinical trial, uniQure's gene therapy AMT-130 slowed Huntington's disease progression by 75% over 3 years. The one-time treatment may mark the first disease-modifying therapy for this incurable neurodegenerative condition.

Medical Daily

Scientists make breakthrough that could halt spread of aggressive cancer

Researchers have found that blocking a protein known as SPP1 extended survival time for patients diagnosed with pancreatic cancer

The Independent UK

‘I became more and more tired – and then was diagnosed with a rare disease and liver failure’

With transplant waiting lists hitting record highs, 29-year-old Katie Howard faces years of putting her life on hold

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

uniQure Stock Doubles On Promising Data From Huntington's Disease Trial

uniQure N.V. (NASDAQ:QURE) on Wednesday released topline data from the pivotal Phase 1/2 study of AMT-130 for Huntington’s disease.

Benzinga

42 Rare Diseases That Sound Like A Science Fiction Plot But Are 100% Real

Ever heard of "hysterical pregnancies"?

Bored Panda

Huntington’s disease treated successfully for first time in UK gene therapy trial

Surgical procedure to treat devastating illness slowed progress of disease by 75% in patients after three years

The Guardian - UK

Huntington’s treatment slows disease for first time in major breakthrough

The condition, which currently has no cure, has been slowed in a groundbreaking trial

The Independent UK

Huntington’s disease slowed for first time by 'groundbreaking' new treatment

University College London experts say the finding could ‘change everything’ for patients with the condition

Evening Standard

Groundbreaking study identifies early symptoms of incurable disease

A new study has pinpointed the earliest features of MS

The Independent UK

‘Lyme disease ruined my life – I was misdiagnosed with hypochondria and depression for over 20 years’

AS TOLD TO : Frédéric Roscop, 49, contracted Lyme disease aged five years old but wasn’t diagnosed with it until his mid-thirties. He tells Charlotte Cripps about his lifelong battle with the disease, along with co-infections and associated mental health challenges, and how he found his way to a normal…

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

AAP

Hird, Heppell and H-Man team up at Scleroderma pop-up

James Hird has thrown his support behind the latest initiative from 13-year-old Harrison Pennicott, who has autoimmune disease Scleroderma, and Dyson Heppell.

Barchart

2 ‘Strong Buy’ Stocks That Wall Street Believes Can Soar 360% to 780%

These two growth stocks are attractive for investors seeking big upside in exchange for higher risk.

Al Jazeera

Spread of diseases overwhelms Khartoum hospitals in war-ravaged Sudan

More than 5,000 cases of malaria, typhoid and dengue fever, causing dozens of deaths, were reported in last month.

The Independent UK

NHS risks missing ‘new era’ of Alzheimer’s treatment without major reforms, experts warn

A new ‘medical revolution’ in treating Alzheimer’s disease is coming, a leading professor says

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

NHS ‘not ready’ for new era of Alzheimer’s diagnosis and treatment, experts say

It comes as a series of papers by 40 experts said a ‘concerted societal effort’ is needed to ensure patients benefit fully from scientific advances.

The Guardian - UK

Disease X: Hunting the Next Pandemic review – an hour of pure terror

Dr Chris van Tulleken learns that Covid-19 was nothing compared to what’s coming to wipe us out. Still, at least he’s like a jolly old uncle as he delivers the bad news

The Independent UK

How genetically modified mice could save a Massachusetts vacation town from a disease outbreak

Researchers believe replacing the current mice population with rodents that are immune to Lyme disease will keep residents from becoming infected

Benzinga

Ionis Pharmaceuticals Reveals 'Unprecedented Results' From Rare Neurological Disease Trial

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) released topline results on Monday from the pivotal study of zilganersen in children and adults living with Alexander disease (AxD), a rare, progressive, and often fatal neurological condition.

The Independent UK

Study lists daily habits that can slow dementia

Same lifestyle changes proven effective for reducing heart disease risk can also help reduce cognitive decline

The Guardian - UK

TV tonight: hunting the virus that could cause the next pandemic

Dr Chris van Tulleken goes in search of the disease that would Covid look like a ‘warning shot’. Plus: fun thriller The Guest concludes. Here’s what to watch this evening

The Guardian - US

States rally to offset fracturing of federal healthcare agencies: ‘Diseases don’t see state lines’

Changes to regulatory or information environments will help states decouple from federal health recommendations

1 … 24 25 26 27

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Ionis Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.